22 Feb 2011 Transgene Announces the Termination by Roche of the License Agreement on TG4001/RG3484 for the Treatment of Diseases Caused by the Human Papilloma Virus (''HPV'')
21 Feb 2011 Intercell announces start of pivotal Phase II/III study in India for vaccine to protect children from Japanese Encephalitis
18 Feb 2011 Clinical Responses Demonstrated in Metastatic Castrate Resistant Prostate Cancer Patients Treated With BPX-101 Cancer Vaccine
18 Feb 2011 NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting
18 Feb 2011 Prima BioMed Receives Regulatory Scientific Advice on CVac Phase III Trial
16 Feb 2011 New Pneumococcal Vaccine Approach Successful in Early Tests
14 Feb 2011 Diamyd Medical: Last Patient Completes the EU Phase III Study of Diamyd® Antigen Based Therapy for Type 1 Diabetes
09 Feb 2011 Liquidia Technologies Announces Collaboration with the Path Malaria Vaccine Initiative
08 Feb 2011 Medicago receives FDA regulatory clearance to initiate U.S. clinical trial for a new influenza vaccine candidate
07 Feb 2011 Inovio Pharmaceuticals Unveils Needle-free, Contactless Electroporation Technology for DNA Vaccine Delivery
03 Feb 2011 New England Journal of Medicine Publishes Efficacy and Safety Data for GARDASIL in Males
02 Feb 2011 Inovio Pharmaceuticals' Dual-Antigen SynCon DNA Vaccine for Prostate Cancer Induces Robust Responses in Preclinical Trial
02 Feb 2011 ImmunoCellular Therapeutics Announces First Patient Enrolled In Its Phase II Trial of ICT-107
02 Feb 2011 European Commission approves nasal spray vaccine FLUENZ for the prevention of seasonal influenza in children
01 Feb 2011 Bavarian Nordic Completes Smallpox Vaccine Phase 2 Trial in Vulnerable Population
01 Feb 2011 Circassia's ToleroMune(R) T-cell Vaccine Achieves Significant Reduction in Allergy Symptoms in Key Phase II Clinical Study
31 Jan 2011 Sinovac Biotech Files Clinical Trial Applications with SFDA for its Proprietary Pneumococcal Polysaccharides Vaccines (PPV)
31 Jan 2011 FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo, for use in children from 2 years of age
31 Jan 2011 University of Southampton and Inovio Pharmaceuticals Initiate Phase 2 Clinical Study to Evaluate Leukemia DNA Vaccine Using Electroporation Delivery Technology
25 Jan 2011 BioSante Announces FDA Orphan Drug Designation for its Melanoma Cancer Vaccine
25 Jan 2011 Generex to Increase Patient Enrollment of its Phase II Breast Cancer Vaccine Study
25 Jan 2011 GenVec and U.S. Naval Medical Research Center to Collaborate on Vaccine for Dengue Fever
24 Jan 2011 Northwest Biotherapeutics Resuming Enrollment In Promising 240-Patient Clinical Trial of DCVax for Brain Cancer
21 Jan 2011 Joint development of therapeutic cancer vaccine WT4869
14 Jan 2011 Independent Data Safety Monitoring Board Gives “Go-Ahead” to Complete Dosing in First Leg of Advaxis’ Phase II Cervical Dysplasia Trial

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up